International Clinical Trial: A single-arm, single-center clinical study of toripalimab as adjuvant therapy for high-risk clear cell renal cell carcinoma after radical nephrectomy

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115679) titled 'A single-arm, single-center clinical study of toripalimab as adjuvant therapy for high-risk clear cell renal cell carcinoma after radical nephrectomy' on Dec. 30, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University

Condition: Renal clear cell carcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-30

Target Sample Size: Experimental group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=298603

Disclaimer: Curated by HT Syndic...